Literature DB >> 14693085

An evaluation of the role of systemic antibiotic prophylaxis in the control of burn wound infection at the Lagos University Teaching Hospital.

A O Ugburo1, O A Atoyebi, J O Oyeneyin, G O A Sowemimo.   

Abstract

A prospective study was carried out on 61 patients to evaluate the role of systemic antibiotic prophylaxis in the control of burn wound infection. The patients were randomised into three groups: group 1 (n=21) received ampicillin and cloxacillin; group 2 (n=20) received erythromycin and genticin and a control group (n=20) received no systemic chemo prophylaxis. The burn wounds were similarly managed. Wound colonisation was determined from surface wound swab cultures and wound infection was determined from wound biopsy cultures and histopathology. The colonisation time (days) for the groups was 2.90+/-0.92, 3.15+/-0.77 and 3.05+/-0.83 for groups 1 and 2 and the control, respectively. The commonest organism isolated from contaminated wounds was Staphylococcus aureus. Wound infection was established in 5.70+/-1.70, 5.75+/-1.62 and 5.6+/-1.90 days for group 1, group 2 and the control group, respectively. There was no significant difference between wound infection time of control and group 1 nor was there such difference between the control and group 2 (P>0.05). The commonest organism infecting burn wounds in all the groups was Pseudomonas aeruginosa followed by S. aureus. There was however a significant difference between the treatment groups and the control (P<0.05) with regard to the percentage of infected wounds that grew P. aeruginosa, compared to those that grew S. aureus. It was concluded that systemic antibiotic prophylaxis is of no value in controlling burn wound sepsis, and might even favour the growth of P. aeruginosa in the burn wounds.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14693085     DOI: 10.1016/j.burns.2003.09.016

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  10 in total

1.  Evolution of an incompatibility group IncA/C plasmid harboring blaCMY-16 and qnrA6 genes and its transfer through three clones of Providencia stuartii during a two-year outbreak in a Tunisian burn unit.

Authors:  C Arpin; L Thabet; H Yassine; A A Messadi; J Boukadida; V Dubois; L Coulange-Mayonnove; C Andre; C Quentin
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

Review 2.  [Antimicrobial treatment in burn injury patients].

Authors:  T Trupkovic; J Gille; H Fischer; S Kleinschmidt
Journal:  Anaesthesist       Date:  2012-03       Impact factor: 1.041

Review 3.  Ichthyosis in the newborn.

Authors:  Brittany G Craiglow
Journal:  Semin Perinatol       Date:  2013-02       Impact factor: 3.300

4.  Burns in Nigeria: a review.

Authors:  A O Oladele; J K Olabanji
Journal:  Ann Burns Fire Disasters       Date:  2010-09-30

5.  Role of the antioxidant effect of vitamin e with vitamin C and topical povidone-iodine ointment in the treatment of burns.

Authors:  A A Al-Kaisy; A Salih Sahib
Journal:  Ann Burns Fire Disasters       Date:  2005-03-31

Review 6.  Prophylactic antibiotics for burns patients: systematic review and meta-analysis.

Authors:  Tomer Avni; Ariela Levcovich; Dean D Ad-El; Leonard Leibovici; Mical Paul
Journal:  BMJ       Date:  2010-02-15

Review 7.  Routine systemic antibiotic prophylaxis for burn injuries in developing countries: A best evidence topic (BET).

Authors:  Barclay T Stewart; Adam Gyedu; Pius Agbenorku; Richcane Amankwa; Adam L Kushner; Nicole Gibran
Journal:  Int J Surg       Date:  2015-08-07       Impact factor: 6.071

8.  Prophylactic Antibiotics May Improve Outcome in Patients With Severe Burns Requiring Mechanical Ventilation: Propensity Score Analysis of a Japanese Nationwide Database.

Authors:  Takashi Tagami; Hiroki Matsui; Kiyohide Fushimi; Hideo Yasunaga
Journal:  Clin Infect Dis       Date:  2015-09-24       Impact factor: 9.079

9.  Extensive colonization with carbapenemase-producing microorganisms in Romanian burn patients: infectious consequences from the Colectiv fire disaster.

Authors:  L E Pirii; A W Friedrich; J W A Rossen; W Vogels; G I J M Beerthuizen; M K Nieuwenhuis; A M D Kooistra-Smid; E Bathoorn
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-10-23       Impact factor: 3.267

10.  The A2B trial, antibiotic prophylaxis for excision-graft surgery in burn patients: a multicenter randomized double-blind study.

Authors:  François Dépret; Boris Farny; Mathieu Jeanne; Kada Klouche; Thomas Leclerc; Karine Nouette-Gaulain; Olivier Pantet; Francis Rémerand; Antoine Roquilly; Anne-Françoise Rousseau; Simon Sztajnic; Sandrine Wiramus; Eric Vicaut; Matthieu Legrand
Journal:  Trials       Date:  2020-11-25       Impact factor: 2.279

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.